Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | doxorubicin | 4044 | drug-path |
Gap junction | R-HSA-190861 | map04540 | doxorubicin | 4044 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | doxorubicin | 4044 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | doxorubicin | 4044 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | doxorubicin | 4044 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | doxorubicin | 4044 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | doxorubicin | 4044 | drug-path |
Proteasome | R-HSA-68819 | map03050 | doxorubicin | 4044 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | doxorubicin | 4044 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | doxorubicin | 4044 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | doxorubicin | 4044 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | doxorubicin | 4044 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | doxorubicin | 4044 | drug-path |
ABC transporters | R-HSA-1369007 | map02010 | doxorubicin | 4044 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | doxorubicin | 4044 | drug-path |
Shigellosis | 0 | map05131 | velnacrine | 5694 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | velnacrine | 5694 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | velnacrine | 5694 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | velnacrine | 5694 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | protriptyline | 4976 | drug-path |